Table 1.
Clinical characteristics and outcomes of COVID patients treated by prone position combine with HFNC
| Case no. | Gender | Age (years) | Comorbidity | Imagine features | Time from illness onset to hospitalization | Baseline PF (onset of HFNC) (mmHg) | WBC (× 109/L) | L (× 109/L) | PCT (ng/ml) | CRP (mg/L) | D-dimer (mg/L) | Intubation | Length of stay (days) | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Male | 54 | Bilateral lobes, GGO and consolidation | 10 | 156.8 | 5.2 | 0.8 | 0.1 | 111.2 | 2.4 | No | 18 | Survivor | |
| 2 | Female | 56 | DM | Bilateral lobes, GGO | 5 | 169.2 | 5.4 | 1.0 | 0.3 | 8.2 | 1.0 | No | 19 | Survivor |
| 3 | Male | 47 | DM, HBP | Bilateral pulmonary infiltration | 10 | 123.6 | 9.6 | 1.0 | 0.2 | 84.0 | 0.2 | No | 11 | Survivor |
| 4 | Female | 65 | Bilateral lobes, GGO | 6 | 117.7 | 6.6 | 0.4 | 0.2 | 97.3 | 3.0 | No | 11 | Survivor | |
| 5 | Female | 51 | HBP | Bilateral pulmonary infiltration | 10 | 205.8 | 6.2 | 0.6 | 0.1 | 110.2 | 0.6 | No | 11 | Survivor |
| 6 | Male | 43 | Bilateral lobes, GGO and consolidation | 6 | 188.8 | 2.2 | 0.8 | < 0.1 | 27.7 | 1.2 | No | 15 | Survivor | |
| 7 | Female | 48 | HBP | Bilateral lobes, GGO and consolidation | 9 | 89.1 | 4.7 | 0.5 | < 0.1 | 47.4 | 0.9 | No | 30 | Survivor |
| 8 | Female | 51 | Bilateral lobes, GGO and consolidation | 5 | 155.5 | 9.5 | 2.0 | < 0.1 | 68.3 | 0.4 | No | 22 | Survivor | |
| 9 | Male | 56 | HBP | Bilateral lobes, GGO and consolidation | 6 | 227.8 | 3.6 | 1.1 | < 0.1 | 15.3 | 2.3 | No | 19 | Survivor |
| 10 | Male | 31 | Bilateral lobes, GGO and consolidation | 1 | 134.7 | 4.2 | 1.4 | 0.2 | 9.5 | 1.9 | No | 21 | Survivor |